Literature DB >> 23841717

The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008-2012.

J D M Edgar1, M Buckland, D Guzman, N P Conlon, V Knerr, C Bangs, V Reiser, Z Panahloo, S Workman, M Slatter, A R Gennery, E G Davies, Z Allwood, P D Arkwright, M Helbert, H J Longhurst, S Grigoriadou, L A Devlin, A Huissoon, M T Krishna, S Hackett, D S Kumararatne, A M Condliffe, H Baxendale, K Henderson, C Bethune, C Symons, P Wood, K Ford, S Patel, R Jain, S Jolles, T El-Shanawany, H Alachkar, A Herwadkar, R Sargur, A Shrimpton, G Hayman, M Abuzakouk, G Spickett, C J Darroch, S Paulus, S E Marshall, E M McDermott, P T Heath, R Herriot, S Noorani, M Turner, S Khan, B Grimbacher.   

Abstract

This report summarizes the establishment of the first national online registry of primary immune deficency in the United Kingdom, the United Kingdom Primary Immunodeficiency (UKPID Registry). This UKPID Registry is based on the European Society for Immune Deficiency (ESID) registry platform, hosted on servers at the Royal Free site of University College, London. It is accessible to users through the website of the United Kingdom Primary Immunodeficiency Network (www.ukpin.org.uk). Twenty-seven centres in the United Kingdom are actively contributing data, with an additional nine centres completing their ethical and governance approvals to participate. This indicates that 36 of 38 (95%) of recognized centres in the United Kingdom have engaged with this project. To date, 2229 patients have been enrolled, with a notable increasing rate of recruitment in the past 12 months. Data are presented on the range of diagnoses recorded, estimated minimum disease prevalence, geographical distribution of patients across the United Kingdom, age at presentation, diagnostic delay, treatment modalities used and evidence of their monitoring and effectiveness.
© 2013 British Society for Immunology.

Entities:  

Keywords:  human studies; immunodeficiency-primary; infections; intravenous immunoglobulin therapy (IVIG); therapy/immunotherapy

Mesh:

Year:  2014        PMID: 23841717      PMCID: PMC3898556          DOI: 10.1111/cei.12172

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Common variable immunodeficiency: clinical and immunological features of 248 patients.

Authors:  C Cunningham-Rundles; C Bodian
Journal:  Clin Immunol       Date:  1999-07       Impact factor: 3.969

2.  Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening.

Authors:  Lucinda Brown; Jinhua Xu-Bayford; Zoe Allwood; Mary Slatter; Andrew Cant; E Graham Davies; Paul Veys; Andrew R Gennery; H Bobby Gaspar
Journal:  Blood       Date:  2011-01-27       Impact factor: 22.113

Review 3.  The long quest for neonatal screening for severe combined immunodeficiency.

Authors:  Rebecca H Buckley
Journal:  J Allergy Clin Immunol       Date:  2012-01-24       Impact factor: 10.793

Review 4.  How I treat common variable immune deficiency.

Authors:  Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2010-03-23       Impact factor: 22.113

5.  Agammaglobulinemia.

Authors:  O C BRUTON
Journal:  Pediatrics       Date:  1952-06       Impact factor: 7.124

6.  Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies.

Authors:  Jordan S Orange; William J Grossman; Roberta J Navickis; Mahlon M Wilkes
Journal:  Clin Immunol       Date:  2010-08-01       Impact factor: 3.969

7.  Management of primary antibody deficiency by consultant immunologists in the United Kingdom: a paradigm for other rare diseases.

Authors:  G P Spickett; T Askew; H M Chapel
Journal:  Qual Health Care       Date:  1995-12

8.  The French national registry of primary immunodeficiency diseases.

Authors: 
Journal:  Clin Immunol       Date:  2010-05       Impact factor: 3.969

Review 9.  Antibody deficiency.

Authors:  R Herriot; W A C Sewell
Journal:  J Clin Pathol       Date:  2008-09       Impact factor: 3.411

10.  Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency.

Authors:  Waleed Al-Herz; Aziz Bousfiha; Jean-Laurent Casanova; Helen Chapel; Mary Ellen Conley; Charlotte Cunningham-Rundles; Amos Etzioni; Alain Fischer; Jose Luis Franco; Raif S Geha; Lennart Hammarström; Shigeaki Nonoyama; Luigi Daniele Notarangelo; Hans Dieter Ochs; Jennifer M Puck; Chaim M Roifman; Reinhard Seger; Mimi L K Tang
Journal:  Front Immunol       Date:  2011-11-08       Impact factor: 7.561

View more
  37 in total

1.  Registries for study of nonmalignant hematological diseases: the example of the Severe Chronic Neutropenia International Registry.

Authors:  David C Dale; Audrey Anna Bolyard; Laurie A Steele; Cornelia Zeidler; Karl Welte
Journal:  Curr Opin Hematol       Date:  2020-01       Impact factor: 3.284

Review 2.  Comprehensive activities to increase recognition of primary immunodeficiency and access to immunoglobulin replacement therapy in Poland.

Authors:  Małgorzata Pac; Ewa Bernatowska
Journal:  Eur J Pediatr       Date:  2016-06-29       Impact factor: 3.183

3.  Effective dosing strategies for therapeutic immunoglobulin: managing wear-off effects in antibody replacement to immunomodulation.

Authors:  S A Misbah
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

4.  The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017.

Authors:  B Shillitoe; C Bangs; D Guzman; A R Gennery; H J Longhurst; M Slatter; D M Edgar; M Thomas; A Worth; A Huissoon; P D Arkwright; S Jolles; H Bourne; H Alachkar; S Savic; D S Kumararatne; S Patel; H Baxendale; S Noorani; P F K Yong; C Waruiru; V Pavaladurai; P Kelleher; R Herriot; J Bernatonienne; M Bhole; C Steele; G Hayman; A Richter; M Gompels; C Chopra; T Garcez; M Buckland
Journal:  Clin Exp Immunol       Date:  2018-06       Impact factor: 4.330

5.  The Swiss National Registry for Primary Immunodeficiencies: report on the first 6 years' activity from 2008 to 2014.

Authors:  K Marschall; M Hoernes; M Bitzenhofer-Grüber; P Jandus; A Duppenthaler; W A Wuillemin; J Rischewski; O Boyman; U Heininger; T Hauser; U Steiner; K Posfay-Barbe; J Seebach; M Recher; C Hess; A Helbling; J Reichenbach
Journal:  Clin Exp Immunol       Date:  2015-07-29       Impact factor: 4.330

6.  Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy.

Authors:  Raffaella Viti; Andrea Marcellusi; Alessandro Capone; Andrea Matucci; Alessandra Vultaggio; Claudio Pignata; Giuseppe Spadaro; Angelo Vacca; Carolina Marasco; Carlo Agostini; Francesco Saverio Mennini
Journal:  Clin Drug Investig       Date:  2018-10       Impact factor: 2.859

7.  Prevalence and morbidity of primary immunodeficiency diseases, United States 2001-2007.

Authors:  Lisa Kobrynski; Rachel Waltenburg Powell; Scott Bowen
Journal:  J Clin Immunol       Date:  2014-09-26       Impact factor: 8.317

8.  An overview of germline variations in genes of primary immunodeficiences through integrative analysis of ClinVar, HGMD® and dbSNP databases.

Authors:  Lyubov E Salnikova; Dmitry S Kolobkov; Darya A Sviridova; Serikbai K Abilev
Journal:  Hum Genet       Date:  2021-07-16       Impact factor: 4.132

9.  Primary Immunodeficiency Diseases in Oman: 10-Year Experience in a Tertiary Care Hospital.

Authors:  Salem Al-Tamemi; Shafiq Ur Rehman Naseem; Nabila Al-Siyabi; Ibtisam El-Nour; Abdulhakim Al-Rawas; David Dennison
Journal:  J Clin Immunol       Date:  2016-10-03       Impact factor: 8.317

10.  Immunoglobulin use in immune deficiency in the UK: a report of the UKPID and National Immunoglobulin Databases.

Authors:  Ben Shillitoe; Rob Hollingsworth; Mark Foster; Tomaz Garcez; David Guzman; J David Edgar; Matthew Buckland
Journal:  Clin Med (Lond)       Date:  2018-10       Impact factor: 2.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.